Recent coverage

Cenkos has released a BUY note on Forbidden, reflecting the company’s strengthened position from a strong balance sheet. Proactive report on the fund raising here and here saying: “It comes as the company has already been buoyed by significant contract wins for the product in recent months”, with Growth Company Investor opening their coverage with a BUY recommendation: “An open offer … will also allow new investors to buy in, with the company offering the same [discounted institutional] price”, and the Daily Mail covering Forbidden today with: “Funds raised will help fund growth. Broker Cenkos is a fan and increased its 2014 revenue forecast from £1.45m to £2m.”